Literature DB >> 26071247

The Incidence of and Risk Factors for 30-Day Surgical Site Infections Following Primary and Revision Total Joint Arthroplasty.

Andrew J Pugely1, Christopher T Martin1, Yubo Gao1, Marin L Schweizer2, John J Callaghan1.   

Abstract

The authors assessed the incidence of and risk factors associated with 30-day surgical site infections (SSIs) following primary (p) and revision (r) THA and TKA. In total, 23,128 primary and 2170 revision TJAs were identified between 2005 and 2010 in the ACS NSQIP database. The 30-day SSI rates, overall and deep, were 1.1 and 0.1% for pTKA, 1.18 and 0.4% for pTHA, 1.68 and 0.7% for rTKA, and 2.9 and 1.7% for rTHA. After primary TJA, independent risk factors were BMI>40, hypertension, prolonged operative time, electrolyte disturbance and previous infection, and after revision TJA, dyspnea and bleeding disorder were risk factors. This study should help provide benchmark data for SSI following TJA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACS NSQIP; primary; revision; surgical site infection; total hip arthroplasty; total knee arthroplasty

Mesh:

Substances:

Year:  2015        PMID: 26071247     DOI: 10.1016/j.arth.2015.01.063

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  28 in total

1.  Infection risk assessment in patients undergoing primary total knee arthroplasty.

Authors:  Lazaros A Poultsides; Georgios K Triantafyllopoulos; Vasileios I Sakellariou; Stavros G Memtsoudis; Thomas P Sculco
Journal:  Int Orthop       Date:  2017-11-12       Impact factor: 3.075

2.  Central sensitization is a risk factor for wound complications after primary total knee arthroplasty.

Authors:  Man Soo Kim; In Jun Koh; Seung Yeol Lee; Yong In
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-24       Impact factor: 4.342

3.  Integrated clinical pathways with watertight, multi-layer closure to improve patient outcomes in total hip and knee joint arthroplasty.

Authors:  Mark A Snyder; Alexandra N Sympson; Steven J Wurzelbacher; Po-Han Brian Chen; Frank R Ernst
Journal:  J Orthop       Date:  2019-09-19

Review 4.  Survivorship and functional outcomes of patellofemoral arthroplasty: a systematic review.

Authors:  J P van der List; H Chawla; H A Zuiderbaan; A D Pearle
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-11-21       Impact factor: 4.342

5.  A 6-year trends analysis of infections after revision total hip arthroplasty.

Authors:  Peter A Gold; Luke J Garbarino; Nipun Sodhi; Hiba K Anis; Joseph O Ehiorobo; Steven M Kurtz; Jonathan R Danoff; Vijay J Rasquinha; Carlos A Higuera; Michael A Mont
Journal:  Ann Transl Med       Date:  2019-02

6.  Variability of patient and surgical risk factors for infection in a single, urban, academic total joint replacement center.

Authors:  Anthony P Gualtieri; Andrew Yoo; Michael S Philips; Joseph Bosco; James Slover
Journal:  J Orthop       Date:  2019-11-13

7.  Chronic preoperative corticosteroid use is not associated with surgical site infection following revision total knee arthroplasty.

Authors:  Safa C Fassihi; Alex Gu; Dana A Perim; Chapman Wei; Seth Stake; Savyasachi Thakkar; Anthony S Unger; Michael P Ast; Peter K Sculco
Journal:  J Orthop       Date:  2020-01-28

8.  Increased antibiotic duration improves reoperation free survival after total hip arthroplasty irrigation and debridement.

Authors:  Nicholas Bene; Xing Li; Sumon Nandi
Journal:  J Orthop       Date:  2018-05-07

9.  Revision Total Shoulder Arthroplasty is Associated with Increased Thirty-Day Postoperative Complications and Wound Infections Relative to Primary Total Shoulder Arthroplasty.

Authors:  Venkat Boddapati; Michael C Fu; William W Schairer; Lawrence V Gulotta; David M Dines; Joshua S Dines
Journal:  HSS J       Date:  2017-09-11

10.  Increased risk of complications in patients with hypoalbuminemia undergoing revision total hip arthroplasty.

Authors:  Nicole D Rynecki; Dominick V Congiusta; Michael Fields; Rushi Patel; Michael M Vosbikian; Irfan H Ahmed
Journal:  J Orthop       Date:  2020-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.